SCHEMBL21039136

SCHEMBL21039136

c1cc(N(c2ccc(-c3cccc4ccccc34)cc2)c2ccc(-c3cccc4ccccc34)cc2)cc(C23CC4CC(CC(C4)C2)C3)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB4 P30926 2/20 0.37
▸ CHRNA3 P32297 2/20 0.37
▸ CHRNA1 P02708 1/20 0.37
▸ CHRNG P07510 1/20 0.37
▸ CHRNB1 P11230 1/20 0.37
▸ CHRNB2 P17787 1/20 0.37
▸ SLC6A2 P23975 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37
▸ CHRNA4 P43681 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ CHRND Q07001 1/20 0.37
▸ MCL1 Q07820 1/20 0.34
▸ ACMSD Q8TDX5 1/20 0.34
▸ CA12 O43570 3/20 0.34
▸ CA1 P00915 3/20 0.34
▸ CA2 P00918 3/20 0.34
▸ CA9 Q16790 3/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21038167 0.97 CHRNA1 (0.38) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL21038195 0.92 CHRNB4 (0.41) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL21039135 0.91 CHRNA1 (0.34) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL21038406 0.91 SLC6A2 (0.40) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL23691175 0.90 ALDH1A1 (0.40) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL19089995 0.89 CA12 (0.39) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL19090019 0.89 CA12 (0.39) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL21038145 0.88 CHRNA1 (0.38) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL19089905 0.87 CA12 (0.37) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL19089825 0.87 CA12 (0.37) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11038111-B2 Organic electroluminescence device and monoamine compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-15 — — US disclosed
US-20190165273-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11038111-B2 Organic electroluminescence device and monoamine compound for organic electroluminescence device MAOA, MAOB, AOC2 CHRNB4 174/4885CHRNA3 146/4885CHRNA1 111/4885
US-20190165273-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE MAOA, MAOB, AOC2 CHRNB4 174/4885CHRNA3 146/4885CHRNA1 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback